Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine
Stewart J Tepper,1 Merrilee R Johnstone2 1Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Prescott Medical Communications Group, Chicago, IL, USA Abstract: There is a need for fast-acting, non-oral medication options for migraine because some attacks develop rapid...
Main Authors: | Tepper SJ, Johnstone MR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | Medical Devices: Evidence and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/breath-powered-sumatriptan-dry-nasal-powder-an-intranasal-medication-d-peer-reviewed-article-MDER |
Similar Items
-
Patient Factors in the Dose Selection of Oral Sumatriptan for Acute Migraine: A Post Hoc Analysis of Two Randomized Controlled Studies
by: Matt Fisher, et al.
Published: (2023-04-01) -
Naproxen sodium decreases migraine recurrence when administered with sumatriptan
by: ABOUCH VALENTY KRYMCHANTOWSKI
Published: (2000-06-01) -
Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery
by: Lígia N. M. Ribeiro, et al.
Published: (2020-11-01) -
Chitosan coating of anionic liposomes containing sumatriptan succinate: a candidate for nasal administration
by: Sara Assadpour, et al.
Published: (2021-04-01) -
Efficacy of Sumatriptan/Placebo versus Sumatriptan/Propofol Combination in Acute Migraine; a Randomized Clinical Trial
by: Reza Farahmand Rad, et al.
Published: (2022-04-01)